IL6 and esophageal squamous cell carcinoma: As mentioned before, CAF-secreted IL-6 stimulates the upregulation of CXCR7 through STAT3/NFκB signaling, promoting resistance of esophageal squamous cell carcinoma cells against cisplatin and 5-FU (Qiao et al., 2018).